Clinical Trial Update: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating AL2846 capsule in combination with TQB2450 injection versus docetaxel in advanced non-small cell lung cancer patients who have failed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AL2846
• DOCETAXEL (DOCETAXEL)
• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING